Trade VYGR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Voyager Therapeutics, Inc. (VYGR) is trading at US$3.09, up 1.64% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$208.88M. Over the past 52 weeks, VYGR has traded between US$2.94 and US$5.55. On Syfe you can trade VYGR with $0 commission and add it to your watchlist.
| Previous close | US$3.04 |
|---|---|
| Market cap | US$208.88M |
| 52-week range | US$2.94 – US$5.55 |
| Volume | 537.81K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Year: 2015
Voyager Therapeutics Expects to Start Early Alzheimer's Study in Adults in H2
Jul 13, 12:35 PM · MT Newswires
Voyager Therapeutics, Inc. (VYGR) stock is trading at US$3.09, +1.64% from the previous close of US$3.04.
The market cap for Voyager Therapeutics, Inc. (VYGR) stock is approximately US$208.88M.
The 52-week high for Voyager Therapeutics, Inc. (VYGR) stock is US$5.55.
The 52-week low for Voyager Therapeutics, Inc. (VYGR) stock is US$2.94.
Voyager Therapeutics, Inc. (VYGR) does not currently pay a dividend.
Stay on top of VYGR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
